HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...

4 analysts have shared their evaluations of Collegium Pharmaceutical (NASDAQ:COLL) during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find ...

In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions. The days of skepticism surrounding ...

In the preceding three months, 27 analysts have released ratings for Biomarin Pharmaceutical (NASDAQ:BMRN), presenting a wide array of perspectives from bullish to bearish. In the table below, you'll ...

LITTLETON, Colo. and CHICAGO, June 3, 2025 /PRNewswire/ -- DeFloria, Inc., the botanical-drug developer advancing the first of its kind AJA001 oral solution for autism spectrum disorder (ASD), today ...

Pharmaceuticals used in health care provide huge health and economic benefits to society, but are now found extensively as ...

Focusing on 2026 as a starting point, PwC has laid out several “strategic imperatives” pharma companies ought to pursue this year, calling on the industry to reinvent R&D, design enduring ...

“The two big problems facing the pharmaceutical industry are price controls and an exaggerated incentive to abandon small molecule drugs in favor of biologics.” Over the last several years the ...

Global market forecasts project a dramatic shift from today's recreational-dominated market to a trillion-dollar pharmaceutical-centric future within the next decade 1. This shift represents the next ...

BUFFALO, N.Y./ONEONTA, N.Y. - SUNY Oneonta and the State University of New York at Buffalo School of Pharmacy and Pharmaceutical Sciences have formed a new collaborative agreement providing qualified ...